Honasa Consumer Limited Acquires 58% Stake in Fluence Pharma to Enter Nutraceuticals Space

Honasa Consumer Limited Acquires 58% Stake in Fluence Pharma to Enter Nutraceuticals Space​

Honasa Consumer Limited, a prominent name in India's beauty and personal care sector, has announced a strategic move into the nutraceuticals industry. The company has acquired a majority stake of 58% in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy (CNT 1) and robust dermatologist-led distribution network.

This acquisition marks Honasa's formal entry into the high-growth nutraceutical market, aiming to build science-backed solutions that address the evolving consumer demand for holistic "inside out" beauty in India. The overall Indian nutraceuticals market is estimated at over INR 16,000 Crore+, driven by increased consumer awareness of nutritional gaps and the expanding role of supplements within the beauty ecosystem.

To execute this strategic expansion, Honasa Consumer Limited will establish a dedicated subsidiary, Honasa Health Private Limited. Under this new entity, the company plans to scale a highly differentiated B2C nutrition portfolio. This strategy combines Fluence's patented clinical science and deep practitioner trust with Honasa's expertise in brand building, consumer insights, and digital-first distribution methods.

Varun Alagh, Co-founder and CEO of Honasa Consumer Limited, stated that the beauty and personal care landscape is shifting toward consumers seeking holistic, inside out solutions for their beauty concerns. He noted that while topical actives defined the last decade, he believes the next will be shaped by the convergence of science backed skin and hair care with nutraceuticals. "Fluence has built a strong scientific foundation through its patented Cyclical Nutrition Therapy," Alagh said. "We are excited to build on this foundation and scale it through Honasa Health, creating a consumer first nutraceuticals franchise that complements our science led beauty portfolio."

Fluence Pharma is founded by Amit Bhusari, a nutraceutical veteran with over 20 years of experience, and Dr. Rajendra Singh Rajput, a world leading trichologist and inventor of Cyclical Nutrition Therapy. The company uses its proprietary CNT to offer condition and gender specific, OTC supplement doses for complex hair and skin conditions.

Backed by over a decade of in clinic performance, Fluence Pharma has garnered the trust of more than 3,000 practicing dermatologists. The company reported approximately INR 40 Crore revenue and an EBITDA margin exceeding 20% in FY26.

Amit Bhusari, CEO and Co-founder of Fluence Pharma, emphasized the importance of unlocking the potential of their proprietary science. He stated that while they focused on grounding the portfolio in science for ten years, they needed a partner to bring these clinical solutions to a wider consumer base. "Honasa Consumer brings the perfect opportunity and infrastructure," Bhusari added. "Their unparalleled digital first capabilities, data driven consumer insights, and proven track record of scaling young brands will allow us to strengthen our distribution and solve consumer problems across India."

The newly incorporated subsidiary, Honasa Health, will be led by Dheeraj Nagpal, CEO of Honasa Health, who possesses over 15 years of consumer business experience. By integrating Fluence's patented science and established dermatologist network with Honasa’s digital capabilities, the new business is positioned to drive long term growth in trusted nutraceuticals.

***

About Honasa Consumer Limited:
Honasa Consumer Limited operates as a purpose driven brand house creating the future of personal care and beauty. As India's largest home grown pure play BPC company, it manages a diverse portfolio of digital first brands including Mamaearth, The Derma Co., Aqualogica, Bblunt, Dr Sheth's, and Staze. Honasa Consumer Limited services over 95% pin codes across the country through its e commerce and D2C online channels, alongside maintaining an offline presence in close to 3 lakh FMCG retail outlets (according to NielsenIQ).

About Fluence Pharma:
Fluence Pharma is a differentiated, science first nutraceutical company founded by Amit Bhusari and Dr. Rajendra Singh Rajput. It is known for its patented Cyclical Nutrition Therapy (CNT) platform and bridges the gap between clinical medicine and daily wellness, delivering high efficacy, practitioner backed formulations with a proven track record of in clinic success.

HONASA Stock Price Movement​

Honasa Consumer Limited shares concluded today, edged higher after gaining 1.00% to settle at ₹419.9. The stock traded within a tight range between a low of ₹412.75 and a high of ₹421.80, with total trading volume reaching 765,764 shares.